Technical Analysis for SNY - Sanofi

Grade Last Price % Change Price Change
grade A 46.17 -0.71% -0.33
SNY closed down 0.71 percent on Friday, October 18, 2019, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical SNY trend table...

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
Stochastic Reached Overbought Strength 0.00%
Overbought Stochastic Strength 0.00%
Pocket Pivot Bullish Swing Setup -0.71%
Gapped Up Strength -0.71%
Up 3 Days in a Row Strength -0.71%
20 DMA Support Bullish 0.94%
Crossed Above 20 DMA Bullish 1.34%
Gapped Up Strength 1.34%
Narrow Range Bar Range Contraction 2.85%

Older signals for SNY ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Sanofi researches, develops, manufactures, and markets healthcare products worldwide. The company operates through Pharmaceuticals, Human Vaccines, and Animal Health segments. Its principal products include Lantus and Apidra analogs of human insulin; Insuman, a range of human insulin solutions and suspensions; Amaryl, an oral once-daily sulfonylurea; BGStar and iBGStar blood glucose meters; enzyme replacement therapies, such as Cerezyme for Gaucher disease, Fabrazyme for Fabry, and Myozyme/Lumizyme for Pompe disease; Aubagio, an oral immunomodulator for multiple sclerosis; Taxotere, a taxane derivative for various cancer types; Eloxatine for colorectal cancer; and Jevtana for prostate cancer. The company's products also consist of thrombosis medicines, such as Plavix anti-platelet agent for atherothrombotic conditions and Lovenox to prevent and treat deep vein thrombosis; and cardiovascular medicines include Multaq anti-arrhythmic agent and Aprovel/CoAprovel for hypertension treatments. It also offers Renagel/Renvela oral phosphate binders used in patients with chronic kidney disease on dialysis to treat high phosphorus levels; Synvisc and Synvisc-One viscosupplements to treat pain associated with osteoarthritis of certain joints; and pediatric and influenza, adult and adolescent booster, meningitis and pneumonia, and travel and endemics vaccines. In addition, the company provides pharmaceuticals and vaccines used by veterinarians, farmers, and pet owners; consumer health care products to treat fever, pain, and digestive health areas; and generic medicines. Sanofi distributes its products through its sales force, as well as through physicians, pharmacies, hospitals, distributors, veterinaries, chemists, and wholesalers. It has alliance arrangements with Bristol-Myers Squibb, Regeneron, and Warner Chilcott. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1970 and is headquartered in Paris, France.
Cancer Healthcare Life Sciences Pharmaceutical Industry Pain Pharmaceuticals Prostate Cancer Multiple Sclerosis Health Sciences Dialysis Influenza Osteoarthritis Chronic Kidney Disease Hypertension Colorectal Cancer Healthcare Products Insulin Cac 40 Hepatotoxins Bristol Myers Squibb Sanofi Fever Pneumonia Pompe Disease Thrombosis Consumer Health Care Products Deep Vein Thrombosis Gaucher Disease Enzyme Replacement Therapies Regeneron
Is SNY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 47.105
52 Week Low 40.0
Average Volume 1,392,844
200-Day Moving Average 43.0017
50-Day Moving Average 44.2316
20-Day Moving Average 45.597
10-Day Moving Average 45.385
Average True Range 0.5951
ADX 15.57
+DI 36.357
-DI 24.006
Chandelier Exit (Long, 3 ATRs ) 45.3197
Chandelier Exit (Short, 3 ATRs ) 45.9218
Upper Bollinger Band 47.0635
Lower Bollinger Band 44.1305
Percent B (%b) 0.7
BandWidth 6.432441
MACD Line 0.3945
MACD Signal Line 0.3709
MACD Histogram 0.0236
Fundamentals Value
Market Cap 115.95 Billion
Num Shares 2.51 Billion
EPS 4.31
Price-to-Earnings (P/E) Ratio 10.71
Price-to-Sales 2.74
Price-to-Book 1.72
PEG Ratio 1.86
Dividend 1.64
Dividend Yield 3.55%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 46.85
Resistance 3 (R3) 46.84 46.60 46.73
Resistance 2 (R2) 46.60 46.43 46.61 46.69
Resistance 1 (R1) 46.39 46.33 46.27 46.40 46.66
Pivot Point 46.15 46.15 46.10 46.16 46.15
Support 1 (S1) 45.94 45.98 45.82 45.95 45.68
Support 2 (S2) 45.70 45.88 45.71 45.65
Support 3 (S3) 45.49 45.70 45.61
Support 4 (S4) 45.50